Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 654 for “"Epithelial-mesenchymal"”.
-
Epithelial-Mesenchymal transition in Breast Cancer Progression
Epithelial-mesenchymal transition (EMT), in which epithelial cells lose their epithelial characteristics and gain mesenchymal features, is a process crucial in cancer progression. EMT induces a phenotypic, molecular and behavioural change in carcinoma cells, permitting them to invade and …
-
MECHANISMS GOVERNING EPITHELIAL MESENCHYMAL TRANSITION IN BLADDER CARCINOMA
Epithelial mesenchymal transition (EMT) is a developmental process governing major steps in morphogenesis and organogenesis. EMT can be induced by a variety of growth factors. EMT is characterized by the loss of apico-basal polarity of epithelial cells and the acquisition of a fibroblastic-like …
-
Gene regulatory networks controlling an epithelial-mesenchymal transition
Epithelial-mesenchymal transitions (EMTs) are fundamental and indispensable to embryonic morphogenesis throughout the animal kingdom. At the onset of gastrulation in the sea urchin embryo, micromere-derived primary mesenchyme cells (PMCs) undergo an EMT process to ingress into the blastocoel, and …
-
SPON2 and its implication in epithelial-mesenchymal transition
Epithelial-mesenchymal transition (EMT) describes a process of differentiation of epithelial cells into cells with mesenchymal properties. EMT is indispensable for normal development, including formation of mesoderm and neural crest, and the same mechanism is also abused by tumour cells to promote …
-
The epithelial-mesenchymal transition of hepatocyte in liver cirrhosis
… cirrhosis is yet undetermined. We surmised that epithelial-mesenchymal transition (EMT) of hepatocytes might contribute to both hepatocyte dysfunction and liver fibrogenesis. To address this issue, hepatocytes were isolated from normal rat liver and from dimethylnitrosamine (DMN)-induced fibrotic …
-
Epithelial-Mesenchymal Transition Opens a Window of Toxicant Sensitivity
… an immortalized but non-malignant bronchial epithelial cell line, has been used extensively to model toxicant-induced carcinogenesis. There are currently inconsistencies in the literature as to which culture media is most appropriate for BEAS-2B, which has profound impacts on cellular …
-
The role of RNA-binding proteins in epithelial-mesenchymal transition
The process of epithelial-mesenchymal transition (EMT) allows carcinoma cells to gain traits that promote cancer metastasis. A key molecular step to the induction of EMT in epithelial cells is decreased expression of the microRNA family, miR-200, which acts as a master regulator of many mRNAs …
-
Epithelial-Mesenchymal Transition in Cancer – Relevance of Periostin Splice Variants
… study represents a comprehensive analysis of the epithelial-mesenchymal transition (EMT) marker periostin and its splice isoforms in renal cell carcinoma (RCC) and in non-small cell lung cancer (NSCLC). EMT can occur in both RCC and NSCLC, but the molecular mechanisms involved in this complex …
-
Exploring Cancer Cell Plasticity: Epithelial-Mesenchymal Transition and Metabolic Reprogramming
… a hallmark of cancer. Cancer cells can utilize epithelial-mesenchymal transition (EMT) to facilitate metastasis. During metastasis, cells do not always undergo a complete EMT, instead a partial EMT, leading to a hybrid epithelial/mesenchymal (E/M) phenotype has often been observed. Cells in the …
-
The role of prostate cancer microvesicles in epithelial mesenchymal transition
… metastasis. Most carcinomas are derived from epithelial cell lines, which normally adhere together tightly to form the structural foundations of many organs. Epithelial Mesenchymal Transition (EMT) has been linked to malignancy in many carcinomas of epithelial origin. In this study, I look at …
-
Cell Signaling Regulatory Mechanisms Controlling Epithelial-Mesenchymal Transition in Carcinoma
Epithelial-mesenchymal transition (EMT) is a cellular program normally engaged during development and wound healing that is hijacked in many cancers to drive metastasis and resistance to therapy. The clinical implications of EMT in cancer progression have driven efforts to understand the cellular …
-
Defining Epithelial-Mesenchymal Plasticity in Cancer Using Single-Cell Genomics
Epithelial-mesenchymal plasticity (EMP) describes the interconversion of cells between epithelial and mesenchymal phenotypes. During the epithelial-mesenchymal transition (EMT), epithelial cells lose defining characteristics, such as stable cell-cell junctions, and gain the ability to migrate and …
-
Dynamic redox signaling during TGF-beta-induced epithelial-mesenchymal transition
… sensitivity and in the context of TGFβ-mediated epithelial-mesenchymal transition (EMT), there exists a possibility of a positive feedback loop operating over multiple temporal and biological scales to stabilize a mesenchymal phenotype. Additionally, drug resistant side populations (SP) arise in …
-
Intersections between epithelial-mesenchymal plasticity and adenosinergic pathway in cancer
Epithelial-mesenchymal transition (EMT) represents an essential process associated with the advancement of tumors, resistance to therapy, and unfavorable prognosis in various cancer types. Nevertheless, the endeavor to focus on EMT or partial-EMT has persisted as a formidable challenge. The CD73 …
-
Epithelial–mesenchymal state encodes distinct signalling behaviours in cancer cells
… influence of clinically relevant axes, such as epithelial–mesenchymal (E/M) status and cell cycle phase, on signalling behaviour remains to be defined. This reflects both conceptual and technical limitations, including the difficulty of capturing cell state and signalling dynamics …
-
Pumilio Regulates the Epithelial-Mesenchymal Transition and Gastrulation During Zebrafish Development
… gene signaling and cell motility, as gained by epithelial-to-mesenchymal transitions (EMT), to occur. In pum1 morphants, both the presentation of wild-type signaling gradients and EMT events are inhibited. Through in silico and in vivo analysis, acvr1b, an Activin receptor, was identified as a …
Page 1 of 33